Compose Health

Market position

Compose Health positions itself as pharma-native AI purpose-built for regulated content workflows, contrasting its approach with general-purpose tools such as Copilot or ChatGPT and with traditional agency-of-record and sequential MLR review processes.

Rather than generating text and then routing it into review, the platform embeds brand, medical, legal and regulatory constraints into the generation step, so review is part of creation. Other stated differentiators include synthetic audience testing that substitutes for panel recruitment, agents tuned to an organization's own standards and voice, automatic generation of documentation and audit trails for regulated approval, and deployment without required systems integration.

Technology

The platform sequences multiple specialized AI agents across content workflow stages rather than providing a single general-purpose assistant, applying brand, medical, legal and regulatory constraints during generation. Additional components include synthetic audience simulation of patients, HCPs and KOLs, a compliance scoring framework, an intelligent editor for audience personalization, and automated logging of AI decisions for audit. The company describes the platform as patented. Infrastructure runs entirely on Microsoft Azure with AES-256 encryption at rest and TLS 1.2 in transit, isolated per-customer environments, five-year audit log retention, and a policy of not training models on customer content without explicit written consent.

Go-to-market

The company markets directly via its website with a 30-minute demo built around a customer's real brand use case, and says the product was created in collaboration with customers and with some of the largest pharma brands. Founders have also promoted the company through industry channels such as the AI For Pharma Growth podcast, and the company has participated in accelerator and ecosystem programs including Techstars AI Health Baltimore and Invest Ottawa events.

Commercial, medical affairs, regulatory and marketing content teams at pharmaceutical companies, including large brands; end audiences addressed by the content include patients, healthcare professionals and key opinion leaders.

Geography

Headquartered in Ottawa, Ontario, Canada, with participation in a Baltimore-based accelerator program; the platform supports translation and localization of global content for local markets and offers local data hosting options.

History

Founded in 2023 in Ottawa, Ontario, Compose Health was publicly discussed by co-founders Patrick Glinski and Ryan Brotman on the AI For Pharma Growth podcast in March 2024. In March 2025 it was named to the Spring 2025 class of the Techstars AI Health Baltimore accelerator powered by Johns Hopkins University and CareFirst BlueCross BlueShield, whose demo day was scheduled for June 5, 2025. In June 2026, Dr. Ellen Campana of Compose Health spoke on an AI-native company building panel at Invest Ottawa's AccelerateOTT 2026 conference.

Risks & controversies

Performance figures such as time and cost savings, approval-readiness timing and pilot results are company-reported and not independently verified in the available material.